XML 90 R74.htm IDEA: XBRL DOCUMENT
v3.26.1

Stockholders' Equity (Deficit) - Common Stock Issuances (Details) - USD ($) |  |  |  |  | 1 Months Ended | 12 Months Ended
--- | --- | --- | --- | --- | --- | ---
Aug. 21, 2024 | May 03, 2024 | Apr. 29, 2024 | Aug. 15, 2023 | Dec. 31, 2024 | Nov. 30, 2024 | Sep. 30, 2024 | Aug. 31, 2024 | Jul. 31, 2024 | Apr. 30, 2024 | Dec. 31, 2025 | Dec. 31, 2024
Stockholders' Equity (Deficit) |  |  |  |  |  |  |  |  |  |  |  |  |
Pursuant to the license and certain milestone achievements stock | [1] |  |  |  |  |  |  |  |  |  |  |  | $ 436,809
Pursuant to the Letter Agreement stock | [2] |  |  |  |  |  |  |  |  |  |  |  | $ 2,322,391
Number of common shares issued |  | 160,624 |  |  |  | 137,500 | 112,500 | 107,875 | 160,624 | 94,697 | 40,297 |  | 653,493
Bausch License Agreement |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Deficit) |  |  |  |  |  |  |  |  |  |  |  |  |
Pursuant to the Letter Agreement shares |  |  | 28,742 |  |  |  |  |  |  |  |  |  |
Pursuant to the Letter Agreement stock |  |  | $ 2,300,000 |  |  |  |  |  |  |  |  |  |
Bausch License Agreement | License |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Deficit) |  |  |  |  |  |  |  |  |  |  |  |  |
Pursuant to the Letter Agreement shares |  |  | 28,742 |  |  |  |  |  |  |  |  |  |
Pursuant to the Letter Agreement stock |  |  | $ 2,300,000 |  |  |  |  |  |  |  |  |  |
Formosa Pharmaceuticals Inc | License |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Deficit) |  |  |  |  |  |  |  |  |  |  |  |  |
Pursuant to the license and certain milestone achievements issued |  |  |  | 7,668 | 6,097 |  |  |  |  |  |  |  |
Pursuant to the license and certain milestone achievements stock |  |  |  | $ 400,000 |  |  |  |  |  |  |  |  |
Merenti Management GmbH |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders' Equity (Deficit) |  |  |  |  |  |  |  |  |  |  |  |  |
Number of common shares issued |  |  |  |  |  |  |  |  |  |  |  | 14,882 |
[1] | Shares issued as partial consideration for License Agreement with Formosa Pharmaceuticals Inc.
[2] | Shares issued as partial consideration for reversion of License Agreement with Bausch & Lomb Ireland Limited.

X
- Definition Represent stock issued period shares licensing agreements. + References No definition available. + Details
Name: | hypd_StockIssuedDuringPeriodSharesLicensingAgreements
Namespace Prefix: | hypd_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represent stock issued period, shares for reacquisition of licensing agreement. + References No definition available. + Details
Name: | hypd_StockIssuedDuringPeriodSharesReacquisitionOfLicensingAgreement
Namespace Prefix: | hypd_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represent stock issued during period value licensing agreements. + References No definition available. + Details
Name: | hypd_StockIssuedDuringPeriodValueLicensingAgreements
Namespace Prefix: | hypd_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Represent stock issued during the period, value for reacquisition of licensing agreements. + References No definition available. + Details
Name: | hypd_StockIssuedDuringPeriodValueReacquisitionOfLicensingAgreement
Namespace Prefix: | hypd_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. References + References No definition available. + Details
Name: | hypd_StockholdersEquityLineItems
Namespace Prefix: | hypd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of new stock issued during the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(4)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(i)(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3 Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1 + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesNewIssues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=hypd_BauschLicenseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=hypd_FormosaPharmaceuticalsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=hypd_MerentiManagementGmbhMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |